Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids
- PMID: 1511438
Comparisons between two monoclonal antibodies that bind to the same antigen but have differing affinities: uptake kinetics and 125I-antibody therapy efficacy in multicell spheroids
Abstract
It has been predicted that low affinity antibodies (Abs) should penetrate into tumors more readily than high affinity Abs. However, the absolute uptake and residence time of a high affinity Ab may be better. It is, therefore, not clear whether a high affinity Ab would have a therapeutic advantage. This is particularly relevant with 125I radioimmunotherapy, where targeting of every cell is important. This study compared the uptake kinetics and toxicity in multicell spheroids of two murine monoclonal Abs labeled with 125I. 17-1A was produced by immunization with a human colon cancer cell line and has an affinity of 5.15 x 10(7) M-1. 323/A3 was produced by immunization with a human breast cancer cell line and has an affinity of 1.87 x 10(9) M-1. Binding of both Abs to LS174T spheroids was similar at 4 degrees C, but binding of 17-1A was 8-10-fold less than that of 323/A3 at 37 degrees C. Despite this difference, the toxicity of 125I-17-1A in spheroids after 7 days of incubation was similar to that of 125I-323/A3. Autoradiography showed that 17-1A penetrated the spheroids much more deeply and evenly than did 323/A3. It appears that much of the radiation dose to spheroids treated with 125I-323/A3 was wasted because of the uneven Ab distribution. This study demonstrates the potential advantage of using Abs of lower affinity for 125I radioimmunotherapy, because of their more even distribution. It also suggests that a large number of binding sites per cell may be a disadvantage if more 125I is bound than is necessary to kill the cell, because this may slow Ab penetration.
Similar articles
-
Iodine-125-NRLU-10 kinetic studies and bismuth-212-NRLU-10 toxicity in LS174T multicell spheroids.J Nucl Med. 1990 Sep;31(9):1527-33. J Nucl Med. 1990. PMID: 2395020
-
Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.Cancer Res. 1987 Mar 15;47(6):1627-33. Cancer Res. 1987. PMID: 3545451
-
Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.J Immunol. 1990 Nov 15;145(10):3507-15. J Immunol. 1990. PMID: 1700013
-
131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids.Cancer Res. 1989 Jun 15;49(12):3401-6. Cancer Res. 1989. PMID: 2720694
-
Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids.Cancer Res. 1988 Apr 1;48(7):1856-63. Cancer Res. 1988. PMID: 3349464
Cited by
-
A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody.Cephalalgia. 2019 Sep;39(10):1284-1297. doi: 10.1177/0333102419840780. Epub 2019 Mar 27. Cephalalgia. 2019. PMID: 30917684 Free PMC article. Review.
-
Radioimmunotherapy: no news from the newcomer.J Cancer Res Clin Oncol. 1994;120(3):121-30. doi: 10.1007/BF01202189. J Cancer Res Clin Oncol. 1994. PMID: 8263007 No abstract available.
-
Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation.Mol Imaging Biol. 2017 Dec;19(6):867-877. doi: 10.1007/s11307-017-1082-x. Mol Imaging Biol. 2017. PMID: 28409338 Free PMC article.
-
Naturally occurring antibodies to epithelial cell adhesion molecule (EpCAM).Dig Dis Sci. 2003 Dec;48(12):2306-9. doi: 10.1023/b:ddas.0000007867.25896.ce. Dig Dis Sci. 2003. PMID: 14714617
-
Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumors.J Neurooncol. 1997 Dec;35(3):259-73. doi: 10.1023/a:1005812417638. J Neurooncol. 1997. PMID: 9440024 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources